These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8321389)

  • 1. Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia.
    Bosman GJ; Visser FE; De Man AJ; Bartholomeus IG; De Grip WJ
    Neurobiol Aging; 1993; 14(3):223-8. PubMed ID: 8321389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte membrane characteristics indicate abnormal cellular aging in patients with Alzheimer's disease.
    Bosman GJ; Bartholomeus IG; de Man AJ; van Kalmthout PJ; de Grip WJ
    Neurobiol Aging; 1991; 12(1):13-8. PubMed ID: 2002877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythrocyte aging characteristics in elderly individuals with beginning dementia.
    Bosman GJ; Janzing JG; Bartholomeus IG; De Man AJ; Zitman FG; De Grip WJ
    Neurobiol Aging; 1997; 18(3):291-5. PubMed ID: 9263194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of aging and neurodegenerative disease on changes in band 3-like proteins in white blood cells.
    Bosman GJ; Steetzel BD; De Man AJ; Van Kalmthout PJ; Visser FE; De Grip WJ
    Mech Ageing Dev; 1995 Apr; 80(1):43-51. PubMed ID: 7564560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte aging in the demented elderly: a fluctuating process?
    Bosman GJ; Van der Linden PA; Bartholomeus IG; De Man AJ; De Grip WJ; Van Kalmthout PJ
    Mech Ageing Dev; 1998 Jan; 100(1):53-8. PubMed ID: 9509394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlative study of the brain CT and clinical features of patients with Down's syndrome in three clinical stages of Alzheimer type dementia].
    Maruyama K; Ikeda S; Yanagisawa N
    Rinsho Shinkeigaku; 1995 Jul; 35(7):775-80. PubMed ID: 8777802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino acids in patients with senile dementia and in subjects with Down's syndrome at an age vulnerable to Alzheimer changes.
    Watkins SE; Thomas DE; Clifford M; Tidmarsh SF; Sweeney AE; Ah-Sing E; Dickerson JW; Cowie VA; Shaw DM
    J Ment Defic Res; 1989 Apr; 33 ( Pt 2)():159-66. PubMed ID: 2524595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome.
    Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A
    Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of hemoglobin denaturation on membrane structure and IgG binding: role in red cell aging.
    Low PS; Kannan R
    Prog Clin Biol Res; 1989; 319():525-46; discussion 547-52. PubMed ID: 2695938
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrocyte anomalies in Down's syndrome.
    Bartosz G; Kedziora J
    Med Hypotheses; 1983 Aug; 11(4):471-7. PubMed ID: 6226851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.
    Hof PR; Bouras C; Perl DP; Sparks DL; Mehta N; Morrison JH
    Arch Neurol; 1995 Apr; 52(4):379-91. PubMed ID: 7710374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down's syndrome and Alzheimer's dementia: defining an association.
    Heston LL
    Psychiatr Dev; 1984; 2(4):287-94. PubMed ID: 6241313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relation between Down's syndrome and Alzheimer-type dementia].
    Steffelaar JW; Bots GT; Evenhuis HM
    Ned Tijdschr Geneeskd; 1988 Aug; 132(33):1516-7. PubMed ID: 2971883
    [No Abstract]   [Full Text] [Related]  

  • 14. Down's syndrome: permeability of the erythrocyte membrane for spin-labeled non-electrolytes.
    Koter M; Kedziora J; Bartosz G; Leyko W
    Experientia; 1982 Dec; 38(12):1447-8. PubMed ID: 6217983
    [No Abstract]   [Full Text] [Related]  

  • 15. Aging of the erythrocyte. VI. Accelerated red cell membrane aging in Down's syndrome?
    Bartosz G; Soszyński M; Kedziora J
    Cell Biol Int Rep; 1982 Jan; 6(1):73-7. PubMed ID: 6459857
    [No Abstract]   [Full Text] [Related]  

  • 16. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranslational modifications of brain and erythrocyte band 3 during aging and disease.
    Kay MM; Rapcsak SZ; Bosman GJ; Goodman JR
    Cell Mol Biol (Noisy-le-grand); 1996 Nov; 42(7):919-44. PubMed ID: 8960771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of cholesterol sulphate in blood plasma and in erythrocyte membranes from individuals with Down's syndrome or diabetes mellitus type I.
    Przybylska M; Bryszewska M; Nowicka U; Szosland K; Kedziora J; Epand RM
    Clin Biochem; 1995 Dec; 28(6):593-7. PubMed ID: 8595707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome.
    Wisniewski HM; Rabe A
    Ann N Y Acad Sci; 1986; 477():247-60. PubMed ID: 2949682
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation of senescent cell antigen on old cells initiates IgG binding to a neoantigen.
    Kay MM
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):131-53. PubMed ID: 8513271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.